PTGS2 and sarcoma: They also found that COX-2 had low expression in feline transitional cell carcinomas, and had no expression in cutaneous squamous cell carcinomas, adenocarcinomas (mammary, pulmonary, and intestinal), lymphomas, or vaccine-associated sarcomas [42].